134 related articles for article (PubMed ID: 6580661)
1. Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis.
Meltzer HY; Busch D
Psychiatry Res; 1983 Aug; 9(4):285-99. PubMed ID: 6580661
[TBL] [Abstract][Full Text] [Related]
2. Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response.
Meltzer HY; Busch DA; Fang VS
Psychiatry Res; 1983 Aug; 9(4):271-83. PubMed ID: 6580660
[TBL] [Abstract][Full Text] [Related]
3. Prolactin secretion response to TRH stimulation in acute and chronic schizophrenic patients under neuroleptic treatment.
Cabranes JA; Fuentenebro F; Recio MN; Borque M; Almoguera MI
Int Pharmacopsychiatry; 1982; 17(1):1-7. PubMed ID: 6123489
[TBL] [Abstract][Full Text] [Related]
4. Effect of intramuscular chlorpromazine on serum prolactin levels in schizophrenic patients and normal controls.
Meltzer HY; Busch DA; Creese IR; Snyder SH; Fang VS
Psychiatry Res; 1981 Aug; 5(1):95-105. PubMed ID: 6944710
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine tests during treatment with neuroleptic drugs: I. Plasma prolactin response to chlorpromazine challenge.
Kolakowska T; Fraser S; Franklin M; Knox J
Psychopharmacology (Berl); 1981; 72(3):283-5. PubMed ID: 6111824
[TBL] [Abstract][Full Text] [Related]
6. Lack of tolerance to long-term neuroleptic treatment in dopamine tuberoinfundibular system.
Chouinard G; Annable L; Jones BD; Collu R
Acta Psychiatr Scand; 1981 Nov; 64(5):353-62. PubMed ID: 6126066
[TBL] [Abstract][Full Text] [Related]
7. Dopamine, serotonin and alpha-adrenergic receptor blocking activities in serum and their relationships to prolactin level in schizophrenic patients receiving long-term chlorpromazine treatment.
Nakahara T; Hirano M; Uchimura H; Saito M; Kim JS; Matsumoto T; Yokoo H; Shimomura M; Mukai A
Psychopharmacology (Berl); 1983; 79(2-3):266-70. PubMed ID: 6133307
[TBL] [Abstract][Full Text] [Related]
8. Relationships between drug concentrations in serum and CSF, clinical effects and monoaminergic variables in schizophrenic patients treated with sulpiride or chlorpromazine.
Alfredsson G; Bjerkenstedt L; Edman G; Härnryd C; Oxenstierna G; Sedvall G; Wiesel FA
Acta Psychiatr Scand Suppl; 1984; 311():49-74. PubMed ID: 6199949
[TBL] [Abstract][Full Text] [Related]
9. Relationship of psychotic symptoms to haloperidol-stimulated prolactin release.
Kulkarni J; Keks NA; Stuart G; Mackie B; Minas IH; Singh BS; Copolov DL
Acta Psychiatr Scand; 1990 Oct; 82(4):271-4. PubMed ID: 2260479
[TBL] [Abstract][Full Text] [Related]
10. Effects of trihexyphenidyl on plasma chlorpromazine in young schizophrenics.
Rockland L; Cooper T; Schwartz F; Weber D; Sullivan T
Can J Psychiatry; 1990 Oct; 35(7):604-7. PubMed ID: 2268840
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of plasma drug and prolactin levels during acute chlorpromazine treatment: a replication study.
Kolakowska T; Orr M; Gelder M; Heggie M; Wiles D; Franklin M
Br J Psychiatry; 1979 Oct; 135():352-9. PubMed ID: 519119
[TBL] [Abstract][Full Text] [Related]
12. Dopamine and serotonin function in untreated schizophrenia: clinical correlates of the apomorphine and d-fenfluramine tests.
Duval F; Mokrani MC; Monreal J; Bailey P; Valdebenito M; Crocq MA; Macher JP
Psychoneuroendocrinology; 2003 Jul; 28(5):627-42. PubMed ID: 12727131
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of plasma chlorpromazine levels. II. Plasma levels of the drug, some of its metabolites and prolactin in patients receiving long-term phenothiazine treatment.
Kolakowska T; Wiles DH; Gelder MG; McNeilly AS
Psychopharmacology (Berl); 1976 Aug; 49(1):101-7. PubMed ID: 8814
[TBL] [Abstract][Full Text] [Related]
14. Lysergic acid diethylamide: evidence for stimulation of pituitary dopamine receptors.
Meltzer HY; Fessler RG; Simonovic M; Doherty J; Fang VS
Psychopharmacology (Berl); 1977 Aug; 54(1):39-44. PubMed ID: 143671
[TBL] [Abstract][Full Text] [Related]
15. Effect of chlorpromazine treatment on prolactin levels in cerebrospinal fluid and plasma of psychotic patients.
Wode-Helgodt B; Eneroth P; Fyrö B; Gullberg B; Sedvall G
Acta Psychiatr Scand; 1977 Oct; 56(4):280-93. PubMed ID: 335789
[TBL] [Abstract][Full Text] [Related]
16. The response of prolactin to chlorpromazine stimulation in men with hypogonadotrophic hypogonadism and early pubertal boys: relationship to sex steroid exposure.
Winters SJ; Johnsonbaugh RE; Sherins RJ
Clin Endocrinol (Oxf); 1982 Apr; 16(4):321-30. PubMed ID: 6807580
[TBL] [Abstract][Full Text] [Related]
17. Correlation between plasma levels of prolactin and chlorpromazine in psychiatric patients.
Kolakowska T; Wiles DH; McNeilly AS; Gelder MG
Psychol Med; 1975 May; 5(2):214-6. PubMed ID: 240179
[TBL] [Abstract][Full Text] [Related]
18. An abnormal relation between basal prolactin levels and prolactin response to 12.5 microg TRH i.v. in drug-naïve patients with first-episode schizophrenia.
Spoov J; Bredbacka PE; Stenman UH
Schizophr Res; 2010 Jun; 119(1-3):41-6. PubMed ID: 20347273
[TBL] [Abstract][Full Text] [Related]
19. Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics.
Csernansky JG; Prosser E; Kaplan J; Mahler E; Berger PA; Hollister LE
Biol Psychiatry; 1986 Jun; 21(7):632-42. PubMed ID: 2871874
[TBL] [Abstract][Full Text] [Related]
20. Prolactin responses to haloperidol in drug-free and treated schizophrenic patients.
Markianos M; Sakellariou G; Bistolaki E
J Neural Transm Gen Sect; 1991; 83(1-2):37-42. PubMed ID: 2018629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
